Grit Bio is a China-based biotechnology company that develops and commercializes tumor infiltrating lymphocytes therapies for the treatment of solid tumor.
Business Model:
Revenue: $4.1M
Employees: 11-50
Address: .
City: Shanghai
State: shanghai municipality
Zip: 200000
Country: CN
Grit Bio is a China-based biotechnology company that develops and commercializes tumor infiltrating lymphocytes therapies for the treatment of solid tumor.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Series A | - | 7/2021 | Series A | 5 | - |
Apricot Capital Decheng Capital Hillhouse Capital Group Matrix Partners China Shanghai Junshi Biosciences Apricot Capital Decheng Capital Hillhouse Capital Group Matrix Partners China Shanghai Junshi Biosciences |
12/2020 | Series A | 2 | $15M |
Decheng Capital Matrix Partners China Decheng Capital Matrix Partners China |
7/2021 | Series A | - |
Apricot Capital Junshi Biosciences Decheng Capital Matrix Partners Apricot Capital Junshi Biosciences Decheng Capital Matrix Partners |
7/2021 | Series A | 5 | - |
Apricot Capital Decheng Capital Hillhouse Capital Group Matrix Partners China Shanghai Junshi Biosciences Apricot Capital Decheng Capital Hillhouse Capital Group Matrix Partners China Shanghai Junshi Biosciences |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|